Anti-DRD1/ D1R/ DADRA monoclonal antibody

Anti-DRD1/ D1R/ DADRA antibody for FACS & in-vivo assay

Target products collectionGo to D1R/DRD1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T22118-Ab-1/ GM-Tg-hg-T22118-Ab-2Anti-Human D1R/DRD1 monoclonal antibodyHuman
GM-Tg-rg-T22118-Ab-1/ GM-Tg-rg-T22118-Ab-2Anti-Rat D1R/DRD1 monoclonal antibodyRat
GM-Tg-mg-T22118-Ab-1/ GM-Tg-mg-T22118-Ab-2Anti-Mouse D1R/DRD1 monoclonal antibodyMouse
GM-Tg-cynog-T22118-Ab-1/ GM-Tg-cynog-T22118-Ab-2Anti-Cynomolgus/ Rhesus macaque D1R/DRD1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T22118-Ab-1/ GM-Tg-felg-T22118-Ab-2Anti-Feline D1R/DRD1 monoclonal antibodyFeline
GM-Tg-cang-T22118-Ab-1/ GM-Tg-cang-T22118-Ab-2Anti-Canine D1R/DRD1 monoclonal antibodyCanine
GM-Tg-bovg-T22118-Ab-1/ GM-Tg-bovg-T22118-Ab-2Anti-Bovine D1R/DRD1 monoclonal antibodyBovine
GM-Tg-equg-T22118-Ab-1/ GM-Tg-equg-T22118-Ab-2Anti-Equine D1R/DRD1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T22118-Ab-1/ GM-Tg-hg-T22118-Ab-2; GM-Tg-rg-T22118-Ab-1/ GM-Tg-rg-T22118-Ab-2;
GM-Tg-mg-T22118-Ab-1/ GM-Tg-mg-T22118-Ab-2; GM-Tg-cynog-T22118-Ab-1/ GM-Tg-cynog-T22118-Ab-2;
GM-Tg-felg-T22118-Ab-1/ GM-Tg-felg-T22118-Ab-2; GM-Tg-cang-T22118-Ab-1/ GM-Tg-cang-T22118-Ab-2;
GM-Tg-bovg-T22118-Ab-1/ GM-Tg-bovg-T22118-Ab-2; GM-Tg-equg-T22118-Ab-1/ GM-Tg-equg-T22118-Ab-2
Products NameAnti-D1R/DRD1 monoclonal antibody
Formatmab
Target NameD1R
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-D1R benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DRD1/ D1R/ DADRA VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMLPm002657mouse Drd1 Lentivirus plasmid
    ORF Viral VectorvGMLPm002657mouse Drd1 Lentivirus particle


    Target information

    Target IDGM-T22118
    Target NameD1R
    Gene ID1812,13488,24316,697796,489110,101085098,281125,100058846
    Gene Symbol and SynonymsC030036C15Rik,D1a,DADR,Drd-1,DRD1,DRD1A,Gpcr15
    Uniprot AccessionP21728,P18901,O77680,Q95136
    Uniprot Entry NameDRD1_HUMAN,DRD1_MACMU,DRD1_RAT,DRD1_BOVIN
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000184845
    Target ClassificationGPCR

    The target: D1R, gene name: DRD1, also named as DADRA, DRD1. This gene encodes the D1 subtype of the dopamine receptor. The D1 subtype is the most abundant dopamine receptor in the central nervous system. This G-protein coupled receptor stimulates adenylyl cyclase and activates cyclic AMP-dependent protein kinases. D1 receptors regulate neuronal growth and development, mediate some behavioral responses, and modulate dopamine receptor D2-mediated events. Alternate transcription initiation sites result in two transcript variants of this gene. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.